Investors Unfazed by Risks Associated With Bayer Drug
480137
The German pharmaceutical giant Bayer is no stranger to health and safety scares. Three years ago, it had to pull its cholesterol-lowering drug Baycol from the market and
753455
Pfizer to investors: Don't stop believing.
193595
A new study states that Bayer AG was too slow in withdrawing Baycol, a cholesterol-lowering medicine called a statin, from the market.
65084
NEW YORK, Feb. 26 -- Shares of United Therapeutics traded heavily Monday as the market reacted to scientific data affecting the Silver Spring drugmaker's lead product, Remodulin.
81346
Never considered drug stocks? You're missing some of the market's best investments.
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
177494
Low-priced stocks can sometimes hold overlooked investment opportunities.
277535
Shares of large U.S. and European drug makers fell on Thursday after a prominent cardiologist questioned the safety of new arthritis drugs and the performance of U.S. regulators in monitoring drug safety.
762997
For the people who have followed closely the unfolding concerns about popular arthritis medicines, the news that Celebrex may also be linked to a higher risk of stroke and heart attack holds little surprise.
2126
Shares of large US and European drug makers fell on Thursday after a prominent cardiologist questioned the safety of new arthritis drugs and the performance of US regulators in monitoring drug safety.
138695
Sirtris has exciting drugs, but is still a pretty risky investment.
526962
As worries for its anemia drugs abate, investors will start to worry about Merck and Novartis.
622013
Stocks closed mixed on Wall Street amid concern over the strength of the pharmaceutical sector after the Pfizerâs announcement on Friday.
140351
NEW YORK - Investors sent stocks sharply lower Thursday as oil prices continued their climb higher and new questions about the safety of arthritis drugs pressured pharmaceutical stocks. The Dow Jones industrials, which include drug makers Pfizer Inc...
184248
Averse to risk? Check out these nontraditional drug companies.
395069
The news seemingly keeps getting worse for Pfizer (NYSE: PFE), but if it can relieve investors&#39; anxiety, the pharmaceutical company stands to be stronger than ever.
758167
Investors should be awake to Lunesta's potential pitfalls.